Conning Inc. lowered its position in shares of Stericycle Inc. (NASDAQ:SRCL) by 55.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,112 shares of the company’s stock after selling 2,675 shares during the period. Conning Inc.’s holdings in Stericycle were worth $220,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in SRCL. Jana Partners LLC bought a new stake in shares of Stericycle during the first quarter worth $305,997,000. Swedbank bought a new stake in shares of Stericycle during the second quarter worth $104,155,000. USS Investment Management Ltd bought a new stake in shares of Stericycle during the first quarter worth $80,866,000. NN Investment Partners Holdings N.V. bought a new stake in shares of Stericycle during the first quarter worth $56,798,000. Finally, Bank of Montreal Can bought a new stake in shares of Stericycle during the second quarter worth $20,213,000. 92.80% of the stock is currently owned by hedge funds and other institutional investors.
Stericycle Inc. (NASDAQ:SRCL) traded down 0.24% during mid-day trading on Thursday, reaching $76.40. 2,045,763 shares of the company’s stock were exchanged. The firm’s 50-day moving average is $81.84 and its 200 day moving average is $99.57. The stock has a market capitalization of $6.50 billion, a PE ratio of 26.89 and a beta of 0.20. Stericycle Inc. has a 1-year low of $75.31 and a 1-year high of $151.57.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting analysts’ consensus estimates of $1.18. The company had revenue of $891.60 million for the quarter, compared to analyst estimates of $910.29 million. Stericycle had a net margin of 7.22% and a return on equity of 14.84%. Stericycle’s quarterly revenue was up 24.6% on a year-over-year basis. During the same period in the previous year, the business posted $1.14 earnings per share. Analysts forecast that Stericycle Inc. will post $4.67 earnings per share for the current fiscal year.
SRCL has been the topic of a number of research analyst reports. RBC Capital Markets reissued an “underperform” rating and set a $77.00 price objective (down from $89.00) on shares of Stericycle in a report on Monday, September 19th. Macquarie started coverage on shares of Stericycle in a report on Thursday, August 25th. They issued a “neutral” rating and a $96.00 price target on the stock. Jefferies Group reaffirmed a “buy” rating and issued a $112.50 price target (down from $125.00) on shares of Stericycle in a report on Wednesday, September 7th. Wellington Shields lowered shares of Stericycle from an “accumulate” rating to a “hold” rating in a report on Friday, July 29th. Finally, Imperial Capital lowered shares of Stericycle from an “in-line” rating to an “underperform” rating and lowered their price target for the company from $100.00 to $93.50 in a report on Friday, July 29th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. Stericycle currently has a consensus rating of “Hold” and an average target price of $103.54.
In other news, Director Mark C. Miller sold 34,835 shares of Stericycle stock in a transaction dated Friday, July 8th. The shares were sold at an average price of $104.52, for a total value of $3,640,954.20. Following the sale, the director now owns 244,284 shares of the company’s stock, valued at $25,532,563.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, EVP John P. Schetz sold 1,398 shares of Stericycle stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total transaction of $114,426.30. Following the completion of the sale, the executive vice president now directly owns 1,088 shares in the company, valued at approximately $89,052.80. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by insiders.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.